We are live on
!
Find out more
TCP
Tourbillon Capital Partners Portfolio holdings
AUM
$6.26M
1-Year Est. Return
42.29%
This Fund
S&P 500
This Quarter
Est. Return
+1.32%
1 Year Est. Return
-42.29%
3 Year Est. Return
-18.38%
5 Year Est. Return
+32.21%
10 Year Est. Return
–
AUM
$5.2B
AUM Growth
+$1.31B
(+34%)
Cap. Flow
+$1.25B
Cap. Flow
% of AUM
24.09%
Top 10 Holdings %
Top 10 Hldgs %
48.23%
Holding
88
New
32
Increased
22
Reduced
14
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Spectrum Brands
SPB
|
+$287M |
| 2 |
Corpay
CPAY
|
+$160M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$88M |
| 4 |
Cognizant
CTSH
|
+$67.5M |
| 5 |
WFM
Whole Foods Market Inc
WFM
|
+$60.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CIT
CIT Group Inc.
CIT
|
+$185M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$145M |
| 3 |
Leidos
LDOS
|
+$67.7M |
| 4 |
Huntington Bancshares
HBAN
|
+$53.9M |
| 5 |
Netflix
NFLX
|
+$51.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 13.81% |
| 2 | Consumer Staples | 12.47% |
| 3 | Healthcare | 11.19% |
| 4 | Technology | 9.38% |
| 5 | Consumer Discretionary | 4.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Scorpio Tankers
STNG
$3.87B
| $18.3M | 0.35% |
+461,000
| New | +$18.6M |
|
|
SHPG
52
CALL
DELISTED
Shire pic
SHPG
| $16.5M | 0.32% |
+100,000
| New | +$17.5M |
|
53
PUT
McDonald's
MCD
$192B
| $15.3M | 0.29% |
+100,000
| New | +$14.5M |
|
|
P
54
CALL
DELISTED
Pandora Media Inc
P
| $15.2M | 0.29% |
+1,700,000
| New | +$16.4M |
|
55
PUT
Apple
AAPL
$4.54T
| $14.4M | 0.28% |
+400,000
| New | +$14.8M |
|
56
PUT
Booking.com
BKNG
$149B
| $14M | 0.27% |
+187,500
| New | +$13.7M |
|
57
Zimmer Biomet
ZBH
$18.2B
| $12.8M | 0.25% |
+103,000
| New | +$12.2M |
|
58
Heron Therapeutics
HRTX
$93.9M
| $11.8M | 0.23% |
850,000
+440,000
| +107% | +$6.37M |
|
|
PTLA
59
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $11.2M | 0.22% |
198,903
-330,000
| -62% | -$13.2M |
|
60
CALL
Sarepta Therapeutics
SRPT
$1.57B
| $11.2M | 0.22% |
331,400
-22,300
| -6% | -$726K |
|
|
61
PUT
Sarepta Therapeutics
SRPT
$1.57B
| $11.2M | 0.22% |
+331,400
| New | +$10.8M |
|
|
FOLD
62
DELISTED
Amicus Therapeutics
FOLD
| $11M | 0.21% |
+1,090,700
| New | +$8.78M |
|
63
CALL
Post Holdings
POST
$4.14B
| $9.32M | 0.18% |
183,360
-618,840
| -77% | -$33.4M |
|
64
Puma Biotechnology
PBYI
$404M
| $8.74M | 0.17% |
100,000
-356,097
| -78% | -$19.9M |
|
|
SIOX
65
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $8.18M | 0.16% |
+44,088
| New | +$7.73M |
|
|
MIC
66
CALL
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $7.84M | 0.15% |
+100,000
| New | +$7.89M |
|
|
PTLA
67
CALL
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $7.83M | 0.15% |
139,400
+35,600
| +34% | +$1.43M |
|
|
CBL
68
DELISTED
CBL& Associates Properties, Inc.
CBL
| $4.21M | 0.08% |
+500,000
| New | +$4.29M |
|
|
WFM
69
PUT
DELISTED
Whole Foods Market Inc
WFM
| $4.21M | 0.08% |
+100,100
| New | +$3.65M |
|
70
PUT
General Mills
GIS
$19.1B
| – | – |
-250,000
| Closed | -$14.8M |
|
|
71
Alphabet (Google) Class A
GOOGL
$4.36T
| – | – |
-3,422,800
| Closed | -$145M |
|
72
CALL
Green Plains
GPRE
$1.18B
| – | – |
-50,000
| Closed | -$1.24M |
|
|
73
Huntington Bancshares
HBAN
$34.4B
| – | – |
-4,027,741
| Closed | -$53.9M |
|
74
CALL
Gartner
IT
$10.1B
| – | – |
-352,900
| Closed | -$38.1M |
|
75
CALL
Jazz Pharmaceuticals
JAZZ
$15.9B
| – | – |
-50,000
| Closed | -$7.26M |
|
Similar funds
BC
LBG
TGA
ACM
MGFS
LA
CT
NMM
Tourbillon Capital Partners's Q2 2017 Portfolio in Review
As of Q2 2017, Tourbillon Capital Partners held 88 positions worth $5.2B, up 34% from $3.88B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Tourbillon Capital Partners deployed $1.25B of net new capital in Q2 2017, opening 32 new positions and adding to 22 existing holdings. Its largest new stake was Spectrum Brands: 2,143,216 shares worth $268M.
By sector, the portfolio is most concentrated in Communication Services at 14% of assets, down from 23% a quarter earlier, followed by Consumer Staples and Healthcare.
On the sell side, the largest reduction was Leidos, an estimated $67.7M trimmed.
- Tourbillon Capital Partners's largest Q2 2017 buy was Spectrum Brands: 2,143,216 shares worth $268M.
- Tourbillon Capital Partners added most to Alexion Pharmaceuticals in Q2 2017, an estimated $88M increase.
- Tourbillon Capital Partners's biggest Q2 2017 reduction was Leidos, cutting an estimated $67.7M.
- Tourbillon Capital Partners fully exited CIT Group Inc. in Q2 2017, selling an estimated $185M.
- Tourbillon Capital Partners's ten largest holdings make up 48% of its $5.2B portfolio in Q2 2017.
- Tourbillon Capital Partners opened 32 new positions and closed 19 in Q2 2017.
- Tourbillon Capital Partners's portfolio value rose 34% quarter-over-quarter to $5.2B.
Based on Tourbillon Capital Partners's 13F filing for Q2 2017, filed 14 Aug 2017.